BioCentury
ARTICLE | Company News

Transgene, Tasly Pharmaceutical deal

August 6, 2012 7:00 AM UTC

Tasly will invest €5.3 million ($6.5 million) in the JV while Transgene will contribute €2.6 million ($3.2 million). Transgene will also contribute IP rights and appoint a CEO of the JV. In February, ...